Connection

Malik Peiris to Middle Aged

This is a "connection" page, showing publications Malik Peiris has written about Middle Aged.
Connection Strength

0.159
  1. Neutralizing antibody titres in SARS-CoV-2 infections. Nat Commun. 2021 01 04; 12(1):63.
    View in: PubMed
    Score: 0.015
  2. SARS-CoV-2 Virus Culture and Subgenomic RNA for Respiratory Specimens from Patients with Mild Coronavirus Disease. Emerg Infect Dis. 2020 11; 26(11):2701-2704.
    View in: PubMed
    Score: 0.014
  3. Infection of dogs with SARS-CoV-2. Nature. 2020 10; 586(7831):776-778.
    View in: PubMed
    Score: 0.014
  4. Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020. Euro Surveill. 2020 04; 25(16).
    View in: PubMed
    Score: 0.014
  5. Population Serologic Immunity to Human and Avian H2N2 Viruses in the United States and Hong Kong for Pandemic Risk Assessment. J Infect Dis. 2018 08 24; 218(7):1054-1060.
    View in: PubMed
    Score: 0.012
  6. Human Infection with Highly Pathogenic Avian Influenza A(H7N9) Virus, China. Emerg Infect Dis. 2017 07; 23(8):1332-1340.
    View in: PubMed
    Score: 0.012
  7. Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels in Nigeria, 2015. Euro Surveill. 2015; 20(49).
    View in: PubMed
    Score: 0.010
  8. Is exercise protective against influenza-associated mortality? PLoS One. 2008 May 07; 3(5):e2108.
    View in: PubMed
    Score: 0.006
  9. Lung pathology of fatal severe acute respiratory syndrome. Lancet. 2003 May 24; 361(9371):1773-8.
    View in: PubMed
    Score: 0.004
  10. SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection. Nat Commun. 2021 07 29; 12(1):4678.
    View in: PubMed
    Score: 0.004
  11. T-cell responses to MERS coronavirus infection in people with occupational exposure to dromedary camels in Nigeria: an observational cohort study. Lancet Infect Dis. 2021 03; 21(3):385-395.
    View in: PubMed
    Score: 0.004
  12. In-Flight Transmission of SARS-CoV-2. Emerg Infect Dis. 2020 11; 26(11):2713-2716.
    View in: PubMed
    Score: 0.004
  13. ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection. Nat Immunol. 2020 10; 21(10):1293-1301.
    View in: PubMed
    Score: 0.004
  14. Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures. Lancet Respir Med. 2020 07; 8(7):687-695.
    View in: PubMed
    Score: 0.004
  15. Viral dynamics in mild and severe cases of COVID-19. Lancet Infect Dis. 2020 06; 20(6):656-657.
    View in: PubMed
    Score: 0.003
  16. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. N Engl J Med. 2020 03 19; 382(12):1177-1179.
    View in: PubMed
    Score: 0.003
  17. Middle East respiratory syndrome coronavirus (MERS-CoV) neutralising antibodies in a high-risk human population, Morocco, November 2017 to January 2018. Euro Surveill. 2019 Nov; 24(48).
    View in: PubMed
    Score: 0.003
  18. Age-specific differences in the dynamics of protective immunity to influenza. Nat Commun. 2019 04 10; 10(1):1660.
    View in: PubMed
    Score: 0.003
  19. Use of influenza antivirals in patients hospitalized in Hong Kong, 2000-2015. PLoS One. 2018; 13(1):e0190306.
    View in: PubMed
    Score: 0.003
  20. Cross-sectional study of MERS-CoV-specific RNA and antibodies in animals that have had contact with MERS patients in Saudi Arabia. J Infect Public Health. 2018 May - Jun; 11(3):331-338.
    View in: PubMed
    Score: 0.003
  21. Viral Shedding and Transmission Potential of Asymptomatic and Paucisymptomatic Influenza Virus Infections in the Community. Clin Infect Dis. 2017 03 15; 64(6):736-742.
    View in: PubMed
    Score: 0.003
  22. Tropism and innate host responses of influenza A/H5N6 virus: an analysis of ex vivo and in vitro cultures of the human respiratory tract. Eur Respir J. 2017 03; 49(3).
    View in: PubMed
    Score: 0.003
  23. A Comparative Study of Clinical Presentation and Risk Factors for Adverse Outcome in Patients Hospitalised with Acute Respiratory Disease Due to MERS Coronavirus or Other Causes. PLoS One. 2016; 11(11):e0165978.
    View in: PubMed
    Score: 0.003
  24. Brief Report: Incubation Period Duration and Severity of Clinical Disease Following Severe Acute Respiratory Syndrome Coronavirus Infection. Epidemiology. 2015 Sep; 26(5):666-9.
    View in: PubMed
    Score: 0.003
  25. Sparse evidence of MERS-CoV infection among animal workers living in Southern Saudi Arabia during 2012. Influenza Other Respir Viruses. 2015 Mar; 9(2):64-7.
    View in: PubMed
    Score: 0.002
  26. MERS coronaviruses in dromedary camels, Egypt. Emerg Infect Dis. 2014 Jun; 20(6):1049-53.
    View in: PubMed
    Score: 0.002
  27. Association of ICAM3 genetic variant with severe acute respiratory syndrome. J Infect Dis. 2007 Jul 15; 196(2):271-80.
    View in: PubMed
    Score: 0.001
  28. The association of RANTES polymorphism with severe acute respiratory syndrome in Hong Kong and Beijing Chinese. BMC Infect Dis. 2007 Jun 01; 7:50.
    View in: PubMed
    Score: 0.001
  29. The large 386-nt deletion in SARS-associated coronavirus: evidence for quasispecies? J Infect Dis. 2006 Sep 15; 194(6):808-13.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.